{
  "ptid_time": "012_S_4094_2011-07-07",
  "img_path": "/data/qiuhui/data/adni/images/012_S_4094/2011-07-07/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 14,639 mm³, 34.5% below the reference mean. With a Z-score of -0.86 (19.4th percentile), this represents normal volume ; hippocampal volume measures 6,935 mm³, 9.8% below the reference mean. With a Z-score of -1.09 (13.7th percentile), this represents mild atrophy; whole brain volume measures 844,743 mm³, 17.9% below the reference mean. With a Z-score of -2.23 (1.3th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,864 mm³, 26.4% below the reference mean. With a Z-score of -2.05 (2.0th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,660 mm³, 19.5% below the reference mean. With a Z-score of -2.20 (1.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 19,363 mm³, 5.6% below the reference mean. With a Z-score of -0.50 (30.8th percentile), this represents normal volume . ",
  "text_data": "Age is 60.0 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 26.0. MoCA: 15.0. Logical Memory: 3.0. Laboratory findings: Lymphocytes: 45.40 (significant elevated); Lymphocytes: 3.90 (profound elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.07 SUVR (normal ); Total tau: 159.40 pg/mL (mild reduced); Phosphorylated tau: 12.99 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in whole brain, entorhinal cortex, and fusiform gyrus volumes (Z-scores ≤ -2.05), along with mild hippocampal atrophy (Z-score -1.09). The MoCA score of 15 is well below the typical cutoff for cognitive impairment (<26), while the MMSE of 26 is borderline. The combination of structural atrophy and cognitive deficits suggests neurodegeneration.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease given entorhinal/hippocampal atrophy, though atypical biomarkers—reduced tau—warrant further investigation).  \n\n**Confidence:** **Medium** (high confidence in dementia due to imaging/cognitive data, but biomarker discrepancies lower certainty about etiology).",
  "timestamp": "2025-07-25T23:11:15.214916"
}